Alkermes - 30 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits. The latest closing stock price for Alkermes as of September 15, 2021 is 30.69.
  • The all-time high Alkermes stock closing price was 98.05 on March 01, 2000.
  • The Alkermes 52-week high stock price is 31.52, which is 2.7% above the current share price.
  • The Alkermes 52-week low stock price is 15.35, which is 50% below the current share price.
  • The average Alkermes stock price for the last 52 weeks is 21.76.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 23.2624 19.7400 31.4100 18.2100 30.6900 53.83%
2020 17.6377 19.7600 22.1000 13.0600 19.9500 -2.21%
2019 25.4200 29.1100 37.3300 17.2900 20.4000 -30.87%
2018 45.9911 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8201 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3880 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2678 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1842 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4301 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4457 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6079 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2140 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9792 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4015 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3925 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0874 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1033 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8799 27.6300 37.1000 17.5000 26.3600 -16.00%
2000 41.5542 25.5000 98.0500 23.6250 31.3800 27.74%
1999 15.7511 11.6900 26.8150 11.4400 24.5650 121.41%
1998 9.9991 9.9400 13.3750 5.3150 11.0950 11.62%
1997 9.5169 11.1900 14.6900 5.1900 9.9400 -14.49%
1996 6.2174 3.7500 12.1250 3.7500 11.6250 192.89%
1995 2.4000 1.0315 4.3125 1.0000 3.9690 273.55%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0673 9.0000 14.1900 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.937B $1.039B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $172.644B 53.33
Bristol Myers Squibb (BMY) United States $138.015B 9.19
Amgen (AMGN) United States $122.679B 13.29
CSL (CSLLY) Australia $99.800B 0.00
Gilead Sciences (GILD) United States $88.331B 8.54
BioNTech SE (BNTX) Germany $81.214B 17.52
Regeneron Pharmaceuticals (REGN) United States $69.002B 11.85
Illumina (ILMN) United States $65.846B 74.81
Vertex Pharmaceuticals (VRTX) United States $48.879B 18.99
Biogen (BIIB) United States $44.106B 12.11
BeiGene (BGNE) Cayman Islands $34.247B 0.00
Genmab (GMAB) Denmark $28.775B 70.66
Genmab (GNMSF) Denmark $28.180B 70.44
Seagen (SGEN) United States $27.374B 46.15
Horizon Therapeutics Public (HZNP) Ireland $23.983B 22.73
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.340B 0.00
Bio-Techne Corp (TECH) United States $19.926B 89.61
Novavax (NVAX) United States $17.451B 0.00
Exact Sciences (EXAS) United States $16.689B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.564B 0.00
Repligen (RGEN) United States $16.169B 123.22
Incyte (INCY) United States $15.953B 37.82
BioMarin Pharmaceutical (BMRN) United States $13.966B 100.22
Guardant Health (GH) United States $12.866B 0.00
Zai Lab (ZLAB) China $12.841B 0.00
QIAGEN (QGEN) Netherlands $12.243B 20.73
CureVac (CVAC) Germany $11.355B 0.00
Intellia Therapeutics (NTLA) United States $11.315B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.862B 22.76
Biohaven Pharmaceutical Holding (BHVN) United States $8.851B 0.00
Ascendis Pharma (ASND) Denmark $8.660B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.456B 30.31
Mirati Therapeutics (MRTX) United States $8.270B 0.00
Acceleron Pharma (XLRN) United States $8.050B 0.00
Beam Therapeutics (BEAM) United States $6.627B 0.00
Vir Biotechnology (VIR) United States $6.553B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.455B 0.00
Sarepta Therapeutics (SRPT) United States $6.410B 0.00
Exelixis (EXEL) United States $6.342B 69.41
Denali Therapeutics (DNLI) United States $6.305B 178.72
Fate Therapeutics (FATE) United States $6.169B 0.00
NeoGenomics (NEO) United States $5.982B 810.83
Halozyme Therapeutics (HALO) United States $5.893B 24.07
Blueprint Medicines (BPMC) United States $5.859B 16.53
Twist Bioscience (TWST) United States $5.623B 0.00
Legend Biotech (LEGN) United States $5.470B 0.00
Certara (CERT) United States $5.338B 0.00
I-Mab (IMAB) China $5.289B 0.00
Adaptive Biotechnologies (ADPT) United States $5.106B 0.00
AbCellera Biologics (ABCL) $4.894B 0.00
Arvinas (ARVN) United States $4.723B 0.00
Editas Medicine (EDIT) United States $4.150B 0.00
Reata Pharmaceuticals (RETA) United States $3.872B 0.00
Galapagos (GLPG) Belgium $3.722B 0.00
Arena Pharmaceuticals (ARNA) United States $3.515B 0.00
SpringWorks Therapeutics (SWTX) United States $3.480B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Prothena (PRTA) Ireland $3.295B 0.00
Kymera Therapeutics (KYMR) United States $3.224B 0.00
ALX Oncology Holdings (ALXO) United States $3.149B 0.00
Insmed (INSM) United States $3.146B 0.00
Emergent Biosolutions (EBS) United States $3.074B 7.41
Amicus Therapeutics (FOLD) United States $2.884B 0.00
Apellis Pharmaceuticals (APLS) United States $2.880B 0.00
Cytokinetics (CYTK) United States $2.764B 0.00
Heska (HSKA) United States $2.716B 520.59
Intra-Cellular Therapies (ITCI) United States $2.666B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.535B 0.00
Seer (SEER) $2.521B 0.00
Myriad Genetics (MYGN) United States $2.485B 0.00
Celldex Therapeutics (CLDX) United States $2.477B 0.00
Morphic Holding (MORF) United States $2.437B 0.00
C4 Therapeutics (CCCC) United States $2.395B 0.00
Vericel (VCEL) United States $2.375B 283.00
Arcus Biosciences (RCUS) United States $2.357B 0.00
Sorrento Therapeutics (SRNE) United States $2.337B 0.00
Atea Pharmaceuticals (AVIR) United States $2.295B 0.00
Ligand Pharmaceuticals (LGND) United States $2.202B 32.21
Berkeley Lights (BLI) United States $2.198B 0.00
Protagonist Therapeutics (PTGX) United States $2.143B 0.00
Instil Bio (TIL) United States $2.125B 0.00
Amarin (AMRN) Ireland $2.044B 517.00
Harmony Biosciences Holdings (HRMY) United States $2.030B 34.57
NGM Biopharmaceuticals (NGM) United States $2.024B 0.00
Myovant Sciences (MYOV) United Kingdom $1.981B 0.00
REGENXBIO (RGNX) United States $1.946B 0.00
Alector (ALEC) United States $1.922B 0.00
Revance Therapeutics (RVNC) United States $1.863B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.845B 0.00
Castle Biosciences (CSTL) United States $1.844B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.819B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
MorphoSys AG (MOR) Germany $1.686B 0.00
UniQure (QURE) Netherlands $1.677B 5.70
Dicerna Pharmaceuticals (DRNA) United States $1.643B 0.00
Global Blood Therapeutics (GBT) United States $1.641B 0.00
Codexis (CDXS) United States $1.615B 0.00
Dynavax Technologies (DVAX) United States $1.597B 0.00
Nurix Therapeutics (NRIX) United States $1.586B 0.00
Inovio Pharmaceuticals (INO) United States $1.584B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.549B 0.00
Zymeworks (ZYME) Canada $1.528B 0.00
Kadmon Holdings (KDMN) United States $1.501B 0.00
Ocugen (OCGN) United States $1.501B 0.00
Bionano Genomics (BNGO) United States $1.452B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.448B 0.00
Travere Therapeutics (TVTX) United States $1.434B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
Scholar Rock Holding (SRRK) United States $1.400B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.381B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.380B 0.00
PureTech Health (PRTC) United States $1.379B 0.00
Sangamo Therapeutics (SGMO) United States $1.328B 0.00
Inhibrx (INBX) United States $1.322B 0.00
Agenus (AGEN) United States $1.303B 0.00
BioAtla (BCAB) United States $1.257B 0.00
Coherus BioSciences (CHRS) United States $1.230B 0.00
MannKind (MNKD) United States $1.188B 0.00
Bluebird Bio (BLUE) United States $1.187B 0.00
Avid Bioservices (CDMO) United States $1.172B 238.88
Repare Therapeutics (RPTX) Canada $1.151B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.136B 0.00
Precigen (PGEN) United States $1.134B 0.00
RAPT THERAPTICS (RAPT) United States $1.096B 0.00
Northwest Biotherapeutics (NWBO) United States $1.066B 0.00
Fulcrum Therapeutics (FULC) United States $1.057B 0.00
ImmunityBio (IBRX) United States $1.021B 0.00
Merus (MRUS) Netherlands $1.021B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.020B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Prometheus Biosciences (RXDX) United States $0.981B 0.00
IDEAYA Biosciences (IDYA) United States $0.968B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.924B 0.00
Sutro Biopharma (STRO) United States $0.923B 0.00
Immatics (IMTX) Germany $0.916B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 28.14
Nkarta (NKTX) United States $0.896B 0.00
BeyondSpring (BYSI) United States $0.882B 0.00
Avidity Biosciences (RNA) United States $0.842B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.829B 0.00
Mesoblast (MESO) Australia $0.825B 0.00
Shattuck Labs (STTK) United States $0.822B 0.00
VBI Vaccines (VBIV) United States $0.794B 0.00
Curis (CRIS) United States $0.748B 0.00
Keros Therapeutics (KROS) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.733B 91.44
Xenon Pharmaceuticals (XENE) Canada $0.723B 0.00
Precision BioSciences (DTIL) United States $0.721B 0.00
Amryt Pharma (AMYT) United Kingdom $0.698B 0.00
AnaptysBio (ANAB) United States $0.697B 0.00
Adagene (ADAG) China $0.683B 0.00
Pliant Therapeutics (PLRX) United States $0.676B 0.00
Pharming Group (PHAR) Netherlands $0.659B 0.00
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.644B 11.74
Sinovac Biotech (SVA) China $0.642B 6.47
Affimed (AFMD) Germany $0.632B 0.00
Cellectis S.A (CLLS) France $0.630B 0.00
MiMedx (MDXG) United States $0.624B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.619B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Ambrx Biopharma (AMAM) United States $0.612B 0.00
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.594B 0.00
G1 THERAPEUTICS (GTHX) United States $0.587B 0.00
Anika Therapeutics (ANIK) United States $0.585B 0.00
Gritstone Bio (GRTS) United States $0.573B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
MeiraGTx Holdings (MGTX) United States $0.559B 0.00
ALBIREO PHARMA (ALBO) United States $0.556B 0.00
Epizyme (EPZM) United States $0.549B 0.00
Vaccitech (VACC) United Kingdom $0.548B 0.00
DBV Technologies S.A (DBVT) France $0.544B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.542B 0.00
Akoya Biosciences (AKYA) United States $0.534B 0.00
Inventiva S.A (IVA) France $0.520B 0.00
Clovis Oncology (CLVS) United States $0.507B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.503B 0.00
Seres Therapeutics (MCRB) United States $0.501B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
Verastem (VSTM) United States $0.475B 0.00
ChromaDex (CDXC) United States $0.475B 0.00
XBiotech (XBIT) United States $0.468B 0.00
Selecta Biosciences (SELB) United States $0.461B 0.00
Cel-Sci (CVM) United States $0.454B 0.00
Clene (CLNN) United States $0.450B 0.00
Bellus Health (BLU) Canada $0.436B 0.00
Innate Pharma S.A (IPHA) France $0.433B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 13.15
Oncobiologics (OTLK) United States $0.423B 0.00
Compugen (CGEN) Israel $0.421B 0.00
Arbutus Biopharma (ABUS) United States $0.421B 0.00
Geron (GERN) United States $0.420B 0.00
Clearside Biomedical (CLSD) United States $0.406B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.394B 0.00
Codiak BioSciences (CDAK) United States $0.390B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
SQZ Biotechnologies (SQZ) United States $0.388B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.378B 0.00
Cue Biopharma (CUE) United States $0.377B 0.00
Cybin (CYBN) Canada $0.375B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.364B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.362B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 9.57
Theratechnologies (THTX) Canada $0.349B 0.00
Athenex (ATNX) United States $0.348B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Opthea (OPT) Australia $0.339B 0.00
Athersys (ATHX) United States $0.330B 0.00
Neoleukin Therapeutics (NLTX) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.326B 0.00
Syros Pharmaceuticals (SYRS) United States $0.326B 0.00
Fortress Biotech (FBIO) United States $0.324B 0.00
Prima BioMed (IMMP) Australia $0.321B 0.00
Cogent Biosciences (COGT) United States $0.320B 0.00
Angion Biomedica (ANGN) United States $0.318B 0.00
INmune Bio (INMB) United States $0.315B 0.00
AquaBounty Technologies (AQB) United States $0.297B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.286B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
Puma Biotechnology (PBYI) United States $0.277B 0.00
XOMA (XOMA) United States $0.270B 113.86
Checkpoint Therapeutics (CKPT) United States $0.259B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Beyond Air (XAIR) United States $0.256B 0.00
IBio (IBIO) United States $0.248B 0.00
Frequency Therapeutics (FREQ) United States $0.240B 0.00
Kamada (KMDA) Israel $0.237B 19.70
Paratek Pharmaceuticals (PRTK) United States $0.233B 0.00
Kaleido Biosciences (KLDO) $0.233B 0.00
OVID THERAPEUTC (OVID) United States $0.231B 2.02
Adicet Bio (ACET) United States $0.231B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.220B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
NextCure (NXTC) United States $0.204B 0.00
Kala Pharmaceuticals (KALA) United States $0.198B 0.00
Trevena (TRVN) United States $0.197B 0.00
Talis Biomedical (TLIS) United States $0.196B 0.00
Seelos Therapeutics (SEEL) United States $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.181B 0.00
TELA Bio (TELA) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
ObsEva SA (OBSV) Switzerland $0.173B 0.00
CorMedix Inc (CRMD) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
VolitionRX (VNRX) United States $0.163B 0.00
HOOKIPA Pharma (HOOK) United States $0.162B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Aptinyx (APTX) United States $0.161B 0.00
Erytech Pharma SA (ERYP) France $0.159B 0.00
Synlogic (SYBX) United States $0.158B 0.00
ADMA Biologics Inc (ADMA) United States $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.154B 0.00
Galena Biopharma (SLS) United States $0.154B 0.00
ATyr Pharma (LIFE) United States $0.152B 0.00
Catalyst Biosciences (CBIO) United States $0.150B 0.00
Dyadic (DYAI) United States $0.150B 0.00
LogicBio Therapeutics (LOGC) United States $0.149B 0.00
Strongbridge Biopharma (SBBP) United States $0.147B 0.00
Vascular Biogenics (VBLT) Israel $0.147B 0.00
VTv Therapeutics (VTVT) United States $0.146B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.136B 0.00
PHASEBIO PHARMA (PHAS) United States $0.135B 0.00
Novogen (KZIA) Australia $0.132B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.124B 0.00
Voyager Therapeutics (VYGR) United States $0.123B 7.07
Evofem Biosciences (EVFM) United States $0.122B 0.00
Orgenesis (ORGS) United States $0.122B 249.00
Eton Pharmaceuticals (ETON) United States $0.121B 0.00
X4 Pharmaceuticals (XFOR) United States $0.120B 0.00
Yumanity Therapeutics (YMTX) United States $0.119B 0.00
Exicure (XCUR) United States $0.118B 0.00
Viridian Therapeutics (VRDN) United States $0.117B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Eyenovia (EYEN) United States $0.115B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
Entera Bio (ENTX) Israel $0.105B 0.00
Palatin Technologies (PTN) United States $0.104B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Armata Pharmaceuticals (ARMP) United States $0.096B 0.00
Pluristem Therapeutics (PSTI) Israel $0.091B 0.00
Aadi Bioscience (AADI) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Lumos Pharma (LUMO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
Aptevo Therapeutics (APVO) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Advaxis (ADXS) United States $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.078B 0.00
AEterna Zentaris (AEZS) United States $0.077B 0.00
Liminal BioSciences (LMNL) Canada $0.077B 0.00
ABVC BioPharma (ABVC) United States $0.074B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
TRACON Pharmaceuticals (TCON) United States $0.072B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Celyad SA (CYAD) Belgium $0.070B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Vyant Bio (VYNT) United States $0.070B 0.00
AIkido Pharma (AIKI) United States $0.069B 0.00
DiaMedica Therapeutics (DMAC) United States $0.068B 0.00
Longeveron (LGVN) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Enveric Biosciences (ENVB) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Forte Biosciences (FBRX) United States $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.09
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Antibe Therapeutics (ATBPF) Canada $0.050B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
Vallon Pharmaceuticals (VLON) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Palisade Bio (PALI) United States $0.033B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
ZIVO Bioscience (ZIVO) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.014B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00